These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26698587)

  • 1. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
    Finkelstein PE
    AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
    [No Abstract]   [Full Text] [Related]  

  • 2. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 3. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

  • 4. Expanded access rules pose quandary for drug developers.
    Mack GS
    Nat Biotechnol; 2009 Oct; 27(10):871-2. PubMed ID: 19816423
    [No Abstract]   [Full Text] [Related]  

  • 5. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
    Bateman-House A; Robertson CT
    JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
    [No Abstract]   [Full Text] [Related]  

  • 6. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
    Puthumana J; Miller JE; Kim J; Ross JS
    JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of 21st Century Cures Act Expanded Access Policies Requirements.
    Kang S; Chang S; Ross JS; Miller JE
    Clin Pharmacol Ther; 2021 Dec; 110(6):1579-1584. PubMed ID: 34431083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TransMolecular receives FDA approval for 131-I-TM-601 IND application.
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):139. PubMed ID: 12113233
    [No Abstract]   [Full Text] [Related]  

  • 9. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 10. Fairer way to distribute last-ditch drugs gets real-world trial.
    Reardon S
    Nature; 2016 Jun; 534(7606):160-1. PubMed ID: 27279187
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
    Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
    Jacob JA
    JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
    [No Abstract]   [Full Text] [Related]  

  • 14. Should patients in need be given access to experimental drugs?
    Caplan AL; Bateman-House A
    Expert Opin Pharmacother; 2015 Jun; 16(9):1275-9. PubMed ID: 26001178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attorneys aim to reform "compassionate use": groups say the regulatory system lags behind scientific advances.
    Printz C
    Cancer; 2015 Jan; 121(2):163-4. PubMed ID: 25581115
    [No Abstract]   [Full Text] [Related]  

  • 16. Looking for a miracle.
    Marchant J
    New Sci; 2000 Jun; 166(2244):16-7. PubMed ID: 11902203
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs with breakthrough status charm investors.
    Senior M
    Nat Biotechnol; 2013 Nov; 31(11):945-7. PubMed ID: 24213748
    [No Abstract]   [Full Text] [Related]  

  • 18. Maine law requires drug companies to provide clinical trial data.
    Appell D
    J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043
    [No Abstract]   [Full Text] [Related]  

  • 19. A critical tipping point.
    Zuckerman MB
    US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing US patent and FDA approval processes: strategically optimizing market exclusivity.
    Fernandez DS; Huie JT
    Drug Discov Today; 2004 Jun; 9(12):509-12. PubMed ID: 15183155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.